BR0116034A - imidazopyridines replaced - Google Patents

imidazopyridines replaced

Info

Publication number
BR0116034A
BR0116034A BR0116034A BR0116034A BR0116034A BR 0116034 A BR0116034 A BR 0116034A BR 0116034 A BR0116034 A BR 0116034A BR 0116034 A BR0116034 A BR 0116034A BR 0116034 A BR0116034 A BR 0116034A
Authority
BR
Brazil
Prior art keywords
imidazopyridines
replaced
useful
compounds
biosynthesis
Prior art date
Application number
BR0116034A
Other languages
Portuguese (pt)
Inventor
Kyle J Lindstrom
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US25422800P priority Critical
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Priority to PCT/US2001/046915 priority patent/WO2002046194A2/en
Publication of BR0116034A publication Critical patent/BR0116034A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Abstract

"IMIDAZOPIRIDINAS SUBSTITUìDAS". "Imidazopyridines replaced." Compostos de imidazopiridina que contêm funcionalidade de amina substituída na posição 1 são úteis como modificadores de resposta imunológica. imidazopyridine compounds that contain substituted amine functionality at the 1-position are useful as immune response modifiers. Os compostos e composições da invenção podem induzir a biosíntese de várias citocinas e são úteis no tratamento de uma variedade de condições incluindo doenças virais e doenças neoplásticas. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in treating a variety of conditions including viral diseases and neoplastic diseases.
BR0116034A 2000-12-08 2001-12-06 imidazopyridines replaced BR0116034A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US25422800P true 2000-12-08 2000-12-08
PCT/US2001/046915 WO2002046194A2 (en) 2000-12-08 2001-12-06 Substituted imidazopyridines

Publications (1)

Publication Number Publication Date
BR0116034A true BR0116034A (en) 2004-08-03

Family

ID=22963437

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0116034A BR0116034A (en) 2000-12-08 2001-12-06 imidazopyridines replaced

Country Status (24)

Country Link
EP (1) EP1343783A2 (en)
JP (1) JP2004525868A (en)
KR (1) KR20030070048A (en)
CN (1) CN1249062C (en)
AR (1) AR035670A1 (en)
AU (2) AU3954702A (en)
BR (1) BR0116034A (en)
CA (1) CA2431040A1 (en)
CZ (1) CZ20031593A3 (en)
EE (1) EE200300273A (en)
HK (1) HK1063466A1 (en)
HR (1) HRP20030465A2 (en)
HU (1) HU0600592A2 (en)
IL (1) IL155885D0 (en)
MX (1) MXPA03005013A (en)
NO (1) NO20032453L (en)
NZ (1) NZ526085A (en)
PL (1) PL365739A1 (en)
RU (1) RU2294934C2 (en)
SK (1) SK7142003A3 (en)
TW (1) TWI243819B (en)
UA (1) UA74593C2 (en)
WO (1) WO2002046194A2 (en)
ZA (1) ZA200305238B (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741908A (en) 1996-06-21 1998-04-21 Minnesota Mining And Manufacturing Company Process for reparing imidazoquinolinamines
EE04314B1 (en) 1997-12-11 2004-06-15 Minnesota Mining And Manufacturing Company Imidasonaftüridiinid and their use in the induction of cytokine biosynthesis
US6756382B2 (en) 1999-06-10 2004-06-29 3M Innovative Properties Company Amide substituted imidazoquinolines
US6541485B1 (en) 1999-06-10 2003-04-01 3M Innovative Properties Company Urea substituted imidazoquinolines
US6331539B1 (en) 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
US6667312B2 (en) 2000-12-08 2003-12-23 3M Innovative Properties Company Thioether substituted imidazoquinolines
US20020107262A1 (en) * 2000-12-08 2002-08-08 3M Innovative Properties Company Substituted imidazopyridines
US6677348B2 (en) 2000-12-08 2004-01-13 3M Innovative Properties Company Aryl ether substituted imidazoquinolines
US6525064B1 (en) 2000-12-08 2003-02-25 3M Innovative Properties Company Sulfonamido substituted imidazopyridines
US6664265B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Amido ether substituted imidazoquinolines
US6545016B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Amide substituted imidazopyridines
US6545017B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Urea substituted imidazopyridines
US6664264B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6660735B2 (en) 2000-12-08 2003-12-09 3M Innovative Properties Company Urea substituted imidazoquinoline ethers
CZ295848B6 (en) 2000-12-08 2005-11-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6677347B2 (en) 2000-12-08 2004-01-13 3M Innovative Properties Company Sulfonamido ether substituted imidazoquinolines
AU2002363954B2 (en) 2001-11-29 2008-04-03 3M Innovative Properties Company Pharmaceutical formulations comprising an immune response modifier
AU2004220469B2 (en) 2001-11-29 2010-07-29 3M Innovative Properties Company Methods of improving skin quality
CA2365732A1 (en) 2001-12-20 2003-06-20 Harm Sluiman Testing measurements
WO2003101949A2 (en) * 2002-05-29 2003-12-11 3M Innovative Properties Company Process for imidazo[4,5-c]pyridin-4-amines
AU2004229478B2 (en) 2003-04-10 2009-12-24 3M Innovative Properties Company Delivery of immune response modifier compounds
EP2269632B1 (en) 2002-08-15 2014-01-01 3M Innovative Properties Co. Immunostimulatory compositions and methods of stimulating an immune response
US6818650B2 (en) 2002-09-26 2004-11-16 3M Innovative Properties Company 1H-imidazo dimers
NZ540826A (en) 2002-12-20 2008-07-31 3M Innovative Properties Co Aryl / hetaryl substituted imidazoquinolines
WO2004060319A2 (en) 2002-12-30 2004-07-22 3M Innovative Properties Company Immunostimulatory combinations
AU2004218349A1 (en) 2003-03-04 2004-09-16 3M Innovative Properties Company Prophylactic treatment of UV-induced epidermal neoplasia
AU2004220466A1 (en) * 2003-03-13 2004-09-23 3M Innovative Properties Company Methods for diagnosing skin lesions
US20040192585A1 (en) 2003-03-25 2004-09-30 3M Innovative Properties Company Treatment for basal cell carcinoma
US6943255B2 (en) 2003-06-06 2005-09-13 3M Innovative Properties Company Process for imidazo[4,5-c]pyridin-4-amines
AU2004266658A1 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Hydroxylamine substituted imidazo-containing compounds
US8961477B2 (en) 2003-08-25 2015-02-24 3M Innovative Properties Company Delivery of immune response modifier compounds
KR101106812B1 (en) 2003-08-27 2012-01-19 쓰리엠 이노베이티브 프로퍼티즈 컴파니 Aryloxy and Arylalkyleneoxy Substituted Imidazoquinolines
WO2005023190A2 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
BRPI0414856A (en) 2003-10-03 2006-11-21 3M Innovative Properties Co alkoxy-substituted imidazoquinoline
WO2005048933A2 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
US8598192B2 (en) 2003-11-14 2013-12-03 3M Innovative Properties Company Hydroxylamine substituted imidazoquinolines
CA2547020C (en) 2003-11-25 2014-03-25 3M Innovative Properties Company 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
WO2005055932A2 (en) 2003-12-02 2005-06-23 3M Innovative Properties Company Therapeutic combinations and methods including irm compounds
JP2007517035A (en) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー Arylalkenyl and arylalkynyl substituted imidazoquinoline
AU2004312510A1 (en) * 2003-12-29 2005-07-21 3M Innovative Properties Company Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds
US8735421B2 (en) 2003-12-30 2014-05-27 3M Innovative Properties Company Imidazoquinolinyl sulfonamides
WO2005094531A2 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US7943609B2 (en) 2004-12-30 2011-05-17 3M Innovative Proprerties Company Chiral fused [1,2]imidazo[4,5-C] ring compounds
AU2005326708C1 (en) 2004-12-30 2012-08-30 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
JP2008530113A (en) 2005-02-11 2008-08-07 コーリー ファーマシューティカル グループ,インコーポレイテッド Oxime and hydroxylamine-substituted imidazo [4,5-c] ring compounds and methods
WO2006107851A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
JP4551962B2 (en) * 2005-09-23 2010-09-29 コーリー ファーマシューティカル グループ,インコーポレイテッド Method for 1H- imidazo [4,5-c] pyridine and its analogues
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
WO2009034411A1 (en) * 2007-09-12 2009-03-19 Centre National De La Recherche Scientifique Perharidines as cdk inhibitors
EP3080112A1 (en) * 2013-12-09 2016-10-19 UCB Biopharma SPRL Imidazopyridine derivatives as modulators of tnf activity
SG11201605296SA (en) 2014-01-10 2016-07-28 Birdie Biopharmaceuticals Inc Compounds and compositions for treating her2 positive tumors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US5389640A (en) * 1991-03-01 1995-02-14 Minnesota Mining And Manufacturing Company 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5268376A (en) * 1991-09-04 1993-12-07 Minnesota Mining And Manufacturing Company 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
DK0708772T3 (en) * 1993-07-15 2000-09-18 Minnesota Mining & Mfg Imidazo [4,5-c] pyridin-4-amines
WO1998030562A1 (en) * 1997-01-09 1998-07-16 Terumo Kabushiki Kaisha Novel amide derivatives and intermediates for the synthesis thereof
EE04314B1 (en) * 1997-12-11 2004-06-15 Minnesota Mining And Manufacturing Company Imidasonaftüridiinid and their use in the induction of cytokine biosynthesis
US6331539B1 (en) * 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
US6451810B1 (en) * 1999-06-10 2002-09-17 3M Innovative Properties Company Amide substituted imidazoquinolines
US6541485B1 (en) * 1999-06-10 2003-04-01 3M Innovative Properties Company Urea substituted imidazoquinolines

Also Published As

Publication number Publication date
SK7142003A3 (en) 2003-10-07
HU0600592A2 (en) 2006-11-28
NO20032453D0 (en) 2003-05-28
KR20030070048A (en) 2003-08-27
AR035670A1 (en) 2004-06-23
PL365739A1 (en) 2005-01-10
MXPA03005013A (en) 2003-09-05
CN1478090A (en) 2004-02-25
RU2294934C2 (en) 2007-03-10
WO2002046194A2 (en) 2002-06-13
WO2002046194A3 (en) 2003-02-06
RU2003116648A (en) 2005-02-10
HRP20030465A2 (en) 2004-06-30
TWI243819B (en) 2005-11-21
JP2004525868A (en) 2004-08-26
EP1343783A2 (en) 2003-09-17
CN1249062C (en) 2006-04-05
IL155885D0 (en) 2003-12-23
NO20032453L (en) 2003-07-16
CZ20031593A3 (en) 2004-01-14
NZ526085A (en) 2004-12-24
EE200300273A (en) 2004-02-16
ZA200305238B (en) 2004-08-27
HK1063466A1 (en) 2006-09-01
CA2431040A1 (en) 2002-06-13
AU3954702A (en) 2002-06-18
UA74593C2 (en) 2003-11-17
AU2002239547B2 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
TW584633B (en) Thioether substituted imidazoquinolines
DK1147114T3 (en) Novel aralkyl of spirofuropyridiner which are suitable for the therapy
AR063555A1 (en) Androstane derivatives, their use in the manufacture of medicaments, pharmaceutical compositions comprising them and processes for preparing
BR0112030A (en) New compounds with antibacterial, antifungal and antitumor
PA8548701A1 (en) azaindoles
DOP2003000639A (en) Pyrazolopyridine substituted carbamate
NO319824B1 (en) Pyrazolkarboksylsyrederivater, their production and use and pharmaceutical compositions containing the same, as well as intermediate compounds.
NO20051469L (en) Immunostimulatory nucleic acids.
CY1116373T1 (en) Pharmaceutical formulations containing methylnaltrexone
BR9714082A (en) Compound, use of the same pharmaceutical composition, and methods for treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound.
BR0313587A (en) Immunostimulatory compositions and methods for stimulating an immune response
NO323698B1 (en) C-aryl glucoside SGLT2 inhibitors, pharmaceutical compositions and combinations containing them, their use for the preparation of pharmaceutical compositions for treatment as well as an intermediate for production.
BR9911482A (en) The compound, pharmaceutical composition, use of the compound, and methods for the treatment or prophylaxis of inflammatory diseases and for preparing a compound
NO333972B1 (en) Combinations of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
SA99200090A (en) Bicyclic hydroxamic acid derivatives.
PA8548001A1 (en) Aromatic dicarboxylic acid derivatives
IS2734B (en) Pýrasólafleiður and use thereof, pharmaceutical compositions
ME00159B (en) Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as ant-inplammatory agents
NO319781B1 (en) 4-amino-2-substituted 1,2,3,4-tetrahydroquinolines as CETP inhibitors, their use and pharmaceutical compositions and kits.
TR200201505T2 (en) Pyrazolopyrimidine days as therapeutic agents
NO327741B1 (en) Heteroaromatic carboxamide derivatives, processes feeder for their preparation, pharmaceutical compositions and the use thereof
BRPI0413860A (en) [1,8] naphthyridin-2-ones and related compounds for the treatment of schizophrenia
MXPA04005362A (en) Thioether substituted imidazoquinolines.
SE9703693D0 (en) Novel combination
ECSP045104A (en) Ligands of cannabinoid receptors

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: CONFORME ARTIGO 10O DA RESOLUCAO 124/06, CABE SER ARQUIVADO REFERENTE AO NAO RECOLHIMENTO DA 6A, 9AE 10A ANUIDADES.

B08K Maintenance of archiving: application remains archived as no request for restauration (art. 87) has been received.

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.